<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>Taxol</title><link>http://www.unboundmedicine.com/medline/ebm/research/Taxol</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Paclitaxel-Eluting Versus Bare-Metal Stents in Acute ST Elevation Myocardial Infarction (STEMI).</title><link>http://www.unboundmedicine.com/medline/ebm/record/19050419/full_citation/Paclitaxel_Eluting_Versus_Bare_Metal_Stents_in_Acute_ST_Elevation_Myocardial_Infarction__STEMI__</link><description>Hamirani YS, Jibrin I, Abraham D, et al. <br/><span class="title">Paclitaxel-Eluting Versus Bare-Metal Stents in Acute ST Elevation Myocardial Infarction (STEMI). [JOURNAL ARTICLE]</span><br/><span class="source" title="Critical pathways in cardiology">Crit Pathw Cardiol 2008 Dec; 7(4):232-238.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19050419/abstract/Paclitaxel_Eluting_Versus_Bare_Metal_Stents_in_Acute_ST_Elevation_Myocardial_Infarction__STEMI__">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19050419/full_citation/Paclitaxel_Eluting_Versus_Bare_Metal_Stents_in_Acute_ST_Elevation_Myocardial_Infarction__STEMI__">Full Citation</a></description></item><item><title>Synergistic anti-tumor effect of paclitaxel with CRM197, an inhibitor of HB-EGF, in ovarian cancer.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19048624/full_citation/Synergistic_anti_tumor_effect_of_paclitaxel_with_CRM197_an_inhibitor_of_HB_EGF_in_ovarian_cancer_</link><description>Yagi H, Yotsumoto F, Sonoda K, et al. <br/><span class="title">Synergistic anti-tumor effect of paclitaxel with CRM197, an inhibitor of HB-EGF, in ovarian cancer. [JOURNAL ARTICLE]</span><br/><span class="source" title="International journal of cancer. Journal international du cancer">Int J Cancer 2008 Sep 30.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19048624/abstract/Synergistic_anti_tumor_effect_of_paclitaxel_with_CRM197_an_inhibitor_of_HB_EGF_in_ovarian_cancer_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19048624/full_citation/Synergistic_anti_tumor_effect_of_paclitaxel_with_CRM197_an_inhibitor_of_HB_EGF_in_ovarian_cancer_">Full Citation</a></description></item><item><title>Phase II evaluation of nedaplatin and paclitaxel in patients with metastatic esophageal carcinoma.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19048253/full_citation/Phase_II_evaluation_of_nedaplatin_and_paclitaxel_in_patients_with_metastatic_esophageal_carcinoma_</link><description>Gong Y, Ren L, Zhou L, et al. <br/><span class="title">Phase II evaluation of nedaplatin and paclitaxel in patients with metastatic esophageal carcinoma. [JOURNAL ARTICLE]</span><br/><span class="source" title="Cancer chemotherapy and pharmacology">Cancer Chemother Pharmacol 2008 Dec 2.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19048253/abstract/Phase_II_evaluation_of_nedaplatin_and_paclitaxel_in_patients_with_metastatic_esophageal_carcinoma_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19048253/full_citation/Phase_II_evaluation_of_nedaplatin_and_paclitaxel_in_patients_with_metastatic_esophageal_carcinoma_">Full Citation</a></description></item><item><title>Breast cancer cells expressing stem cell markers CD44(+) CD24 (lo) are eliminated by Numb-1 peptide-activated T cells.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19048252/full_citation/Breast_cancer_cells_expressing_stem_cell_markers_CD44_+__CD24__lo__are_eliminated_by_Numb_1_peptide_activated_T_cells_</link><description>Mine T, Matsueda S, Li Y, et al. <br/><span class="title">Breast cancer cells expressing stem cell markers CD44(+) CD24 (lo) are eliminated by Numb-1 peptide-activated T cells. [JOURNAL ARTICLE]</span><br/><span class="source" title="Cancer immunology, immunotherapy : CII">Cancer Immunol Immunother 2008 Dec 2.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19048252/abstract/Breast_cancer_cells_expressing_stem_cell_markers_CD44_+__CD24__lo__are_eliminated_by_Numb_1_peptide_activated_T_cells_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19048252/full_citation/Breast_cancer_cells_expressing_stem_cell_markers_CD44_+__CD24__lo__are_eliminated_by_Numb_1_peptide_activated_T_cells_">Full Citation</a></description></item><item><title>Randomized Phase II Study of Pulse Erlotinib Before or After Carboplatin and Paclitaxel in Current or Former Smokers With Advanced Non-Small-Cell Lung Cancer.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19047285/full_citation/Randomized_Phase_II_Study_of_Pulse_Erlotinib_Before_or_After_Carboplatin_and_Paclitaxel_in_Current_or_Former_Smokers_With_Advanced_Non_Small_Cell_Lung_Cancer_</link><description>Riely GJ, Rizvi NA, Kris MG, et al. <br/><span class="title">Randomized Phase II Study of Pulse Erlotinib Before or After Carboplatin and Paclitaxel in Current or Former Smokers With Advanced Non-Small-Cell Lung Cancer. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of clinical oncology : official journal of the American Society of Clinical Oncology">J Clin Oncol 2008 Dec 1.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19047285/abstract/Randomized_Phase_II_Study_of_Pulse_Erlotinib_Before_or_After_Carboplatin_and_Paclitaxel_in_Current_or_Former_Smokers_With_Advanced_Non_Small_Cell_Lung_Cancer_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19047285/full_citation/Randomized_Phase_II_Study_of_Pulse_Erlotinib_Before_or_After_Carboplatin_and_Paclitaxel_in_Current_or_Former_Smokers_With_Advanced_Non_Small_Cell_Lung_Cancer_">Full Citation</a> | <a href="http://www.jco.org/cgi/pmidlookup%3fview=long%26amp;pmid=19047285">Publisher Full Text</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/19047285/Randomized_Phase_II_Study_of_Pulse_Erlotinib_Before_or_After_Carboplatin_and_Paclitaxel_in_Current_or_Former_Smokers_With_Advanced_Non_Small_Cell_Lung_Cancer_">Find Related Articles</a> </description></item><item><title>Tubulin-Targeted Drug Action: Functional Significance of Class II and Class IVb {beta}-Tubulin in Vinca Alkaloid Sensitivity.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19047161/full_citation/Tubulin_Targeted_Drug_Action:_Functional_Significance_of_Class_II_and_Class_IVb_{beta}_Tubulin_in_Vinca_Alkaloid_Sensitivity_</link><description>Gan PP, Kavallaris M <br/><span class="title">Tubulin-Targeted Drug Action: Functional Significance of Class II and Class IVb {beta}-Tubulin in Vinca Alkaloid Sensitivity. [Journal Article]</span><br/><span class="source" title="Cancer research">Cancer Res 2008 Dec 1; 68(23):9817-24.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19047161/abstract/Tubulin_Targeted_Drug_Action:_Functional_Significance_of_Class_II_and_Class_IVb_{beta}_Tubulin_in_Vinca_Alkaloid_Sensitivity_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19047161/full_citation/Tubulin_Targeted_Drug_Action:_Functional_Significance_of_Class_II_and_Class_IVb_{beta}_Tubulin_in_Vinca_Alkaloid_Sensitivity_">Full Citation</a> | <a href="http://cancerres.aacrjournals.org/cgi/pmidlookup%3fview=long%26amp;pmid=19047161">Publisher Full Text</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/19047161/Tubulin_Targeted_Drug_Action:_Functional_Significance_of_Class_II_and_Class_IVb_{beta}_Tubulin_in_Vinca_Alkaloid_Sensitivity_">Find Related Articles</a> </description></item><item><title>HER-2 Gene Amplification, HER-2 and Epidermal Growth Factor Receptor mRNA and Protein Expression, and Lapatinib Efficacy in Women with Metastatic Breast Cancer.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19047115/full_citation/HER_2_Gene_Amplification_HER_2_and_Epidermal_Growth_Factor_Receptor_mRNA_and_Protein_Expression_and_Lapatinib_Efficacy_in_Women_with_Metastatic_Breast_Cancer_</link><description>Press MF, Finn RS, Cameron D, et al. <br/><span class="title">HER-2 Gene Amplification, HER-2 and Epidermal Growth Factor Receptor mRNA and Protein Expression, and Lapatinib Efficacy in Women with Metastatic Breast Cancer. [Journal Article]</span><br/><span class="source" title="Clinical cancer research : an official journal of the American Association for Cancer Research">Clin Cancer Res 2008 Dec 1; 14(23):7861-70.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19047115/abstract/HER_2_Gene_Amplification_HER_2_and_Epidermal_Growth_Factor_Receptor_mRNA_and_Protein_Expression_and_Lapatinib_Efficacy_in_Women_with_Metastatic_Breast_Cancer_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19047115/full_citation/HER_2_Gene_Amplification_HER_2_and_Epidermal_Growth_Factor_Receptor_mRNA_and_Protein_Expression_and_Lapatinib_Efficacy_in_Women_with_Metastatic_Breast_Cancer_">Full Citation</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/19047115/HER_2_Gene_Amplification_HER_2_and_Epidermal_Growth_Factor_Receptor_mRNA_and_Protein_Expression_and_Lapatinib_Efficacy_in_Women_with_Metastatic_Breast_Cancer_">Find Related Articles</a> </description></item><item><title>Cooperation of the Agonistic DR5 Antibody Apomab with Chemotherapy to Inhibit Orthotopic Lung Tumor Growth and Improve Survival.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19047100/full_citation/Cooperation_of_the_Agonistic_DR5_Antibody_Apomab_with_Chemotherapy_to_Inhibit_Orthotopic_Lung_Tumor_Growth_and_Improve_Survival_</link><description>Jin H, Yang R, Ross J, et al. <br/><span class="title">Cooperation of the Agonistic DR5 Antibody Apomab with Chemotherapy to Inhibit Orthotopic Lung Tumor Growth and Improve Survival. [Journal Article]</span><br/><span class="source" title="Clinical cancer research : an official journal of the American Association for Cancer Research">Clin Cancer Res 2008 Dec 1; 14(23):7733-40.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19047100/abstract/Cooperation_of_the_Agonistic_DR5_Antibody_Apomab_with_Chemotherapy_to_Inhibit_Orthotopic_Lung_Tumor_Growth_and_Improve_Survival_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19047100/full_citation/Cooperation_of_the_Agonistic_DR5_Antibody_Apomab_with_Chemotherapy_to_Inhibit_Orthotopic_Lung_Tumor_Growth_and_Improve_Survival_">Full Citation</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/19047100/Cooperation_of_the_Agonistic_DR5_Antibody_Apomab_with_Chemotherapy_to_Inhibit_Orthotopic_Lung_Tumor_Growth_and_Improve_Survival_">Find Related Articles</a> </description></item><item><title>Paclitaxel downregulates tissue factor in cancer and host tumour-associated cells.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19046877/full_citation/Paclitaxel_downregulates_tissue_factor_in_cancer_and_host_tumour_associated_cells_</link><description>Napoleone E, Zurlo F, Latella MC, et al. <br/><span class="title">Paclitaxel downregulates tissue factor in cancer and host tumour-associated cells. [JOURNAL ARTICLE]</span><br/><span class="source" title="European journal of cancer (Oxford, England : 1990)">Eur J Cancer 2008 Nov 27.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19046877/abstract/Paclitaxel_downregulates_tissue_factor_in_cancer_and_host_tumour_associated_cells_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19046877/full_citation/Paclitaxel_downregulates_tissue_factor_in_cancer_and_host_tumour_associated_cells_">Full Citation</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/19046877/Paclitaxel_downregulates_tissue_factor_in_cancer_and_host_tumour_associated_cells_">Find Related Articles</a> </description></item><item><title>Salvage paclitaxel chemotherapy for metastatic collecting duct carcinoma of the kidney.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19046497/full_citation/Salvage_paclitaxel_chemotherapy_for_metastatic_collecting_duct_carcinoma_of_the_kidney_</link><description>Bagrodia A, Gold R, Handorf C, et al. <br/><span class="title">Salvage paclitaxel chemotherapy for metastatic collecting duct carcinoma of the kidney. [Journal Article]</span><br/><span class="source" title="The Canadian journal of urology">Can J Urol 2008 Dec; 15(6):4425-7.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19046497/abstract/Salvage_paclitaxel_chemotherapy_for_metastatic_collecting_duct_carcinoma_of_the_kidney_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19046497/full_citation/Salvage_paclitaxel_chemotherapy_for_metastatic_collecting_duct_carcinoma_of_the_kidney_">Full Citation</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/19046497/Salvage_paclitaxel_chemotherapy_for_metastatic_collecting_duct_carcinoma_of_the_kidney_">Find Related Articles</a> </description></item></channel></rss>